RT Book, Section
A1 Verstovsek, Srdan
A1 Newberry, Kate J.
A1 Amin, Hesham M.
A2 Kantarjian, Hagop M.
A2 Wolff, Robert A.
SR Print(0)
ID 1126740262
T1 Philadelphia Chromosome-Negative Myeloproliferative Neoplasms
T2 The MD Anderson Manual of Medical Oncology, 3e
YR 2016
FD 2016
PB McGraw-Hill Medical
PP New York, NY
SN 9780071847940
LK hemonc.mhmedical.com/content.aspx?aid=1126740262
RD 2024/04/25
AB The  field  of  myeloproliferative  disorders  (MPDs)  has  evolved  considerably  since  the  sentinel  observations  made  by  William  Dameshek  in  1951.  He  had  commented  in  an  editorial  in  the  journal  Blood:  “To  put  together  such  apparently  dissimilar  diseases  as  chronic  granulocytic  leukemia,  polycythemia,  myeloid  metaplasia  and  di  Guglielmo's  syndrome  may  conceivably  be  without  foundation,  but  for  the  moment  at  least,  this  may  prove  useful  and  even  productive.  What  more  can  one  ask  of  a  theory?”  (1).